A mostrar 1 - 2 resultados de 2 para a pesquisa 'Jos M A Kuijlen', tempo de pesquisa: 0.02seg Refinar resultados
  1. 1
    Transforaminal versus posterior lumbar interbody fusion for symptomatic single-level spondylolisthesis (LIFT): a multicentre controlled, patient blinded, randomised non-inferiority trialResearch in context

    Transforaminal versus posterior lumbar interbody fusion for symptomatic single-level spondylolisthesis (LIFT): a multicentre controlled, patient blinded, randomised non-inferiority... Por Inge J.M.H. Caelers, Ruud Droeghaag, Suzanne L. de Kunder, Jasper Most, Kim Rijkers, Ronald H.M.A. Bartels, Jos M.A. Kuijlen, Mark H.H.M. Hulsbosch, Wouter L.W. van Hemert, Rob A. de Bie, Henk van Santbrink

    Publicado em 2024-08-01
    Obter o texto integral
    Artigo
  2. 2
    Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial

    Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for... Por Wouter B Nagengast, J Marc C van Dijk, André P van Beek, Rob A Vergeer, Mark R Postma, Iris Schmidt, Astrid GW Korsten-Meijer, Robert A Feijen, Schelto Kruijff, Wilfred F A den Dunnen, Jos M A Kuijlen, Gerrit van den Berg

    Publicado em 2021-10-01
    Obter o texto integral
    Artigo

Ferramentas de pesquisa: